Center for Lung Cancer, National Cancer Center, Goyang, Republic of Korea.
Eur J Cardiothorac Surg. 2010 Oct;38(4):491-7. doi: 10.1016/j.ejcts.2010.02.033.
Mediastinal nodal metastasis is related to poor prognosis in surgically resected non-small-cell lung cancer (NSCLC) and the prognosis becomes worse with an increasing number of nodal stations involved. However, intra-operative designation of each nodal station might be difficult and confusing because of the adjacency of the nodal stations, and this may cause inaccurate nodal staging. The new concept of a 'nodal zone' was proposed by the IASLC lung cancer staging project (IALC, International Association for the Study of Lung Cancer), and we investigated the impact of the 'nodal zone' on the survival of pathological N2 patients.
From a total of 1186 patients with NSCLC, who underwent surgical resection with curative intent, we analysed the survival data of 217 patients with ipsilateral mediastinal metastasis retrospectively.
The operative mortality rate was 1.4% (three patients) and median follow-up period was 35.4 months. The 5-year overall survival rate was 36.5% (median: 39.3 months; confidence interval (CI): 32.05-46.62). Median disease-free survival was 17.4 months (CI: 13.84-21.03). Overall and disease-free survival were better in the single-zone metastasis group than in the multiple zone group (median: 48.5 vs 33.4 months, p=0.001, CI: 32.05-46.62, and 20.4 vs 10.6 months, p<0.001, CI: 13.84-21.03). Among those of the single nodal zone metastasis group, no differences were found between the single and multiple nodal station metastasis groups in overall and disease-free survival.
Patients with single nodal zone metastasis showed favourable outcomes compared with the multiple zone metastasis group. Even though two or more nodal stations were involved, the outcome was favourable if the nodal stations involved were confined to a single nodal zone. In conclusion, patients with single nodal zone metastasis can benefit from surgical resection.
纵隔淋巴结转移与手术切除的非小细胞肺癌(NSCLC)患者的不良预后有关,且随着淋巴结转移站数的增加,预后越来越差。然而,由于淋巴结站位相邻,术中对每个淋巴结站位的指定可能会很困难且容易混淆,这可能导致淋巴结分期不准确。国际肺癌研究协会(IASLC)肺癌分期项目(IALC)提出了“淋巴结区”的新概念,我们研究了“淋巴结区”对病理性 N2 患者生存的影响。
从 1186 例接受根治性手术切除的 NSCLC 患者中,我们回顾性分析了 217 例同侧纵隔转移患者的生存数据。
手术死亡率为 1.4%(3 例),中位随访时间为 35.4 个月。5 年总生存率为 36.5%(中位数:39.3 个月;置信区间[CI]:32.05-46.62)。无病生存率中位数为 17.4 个月(CI:13.84-21.03)。单区转移组的总生存和无病生存均优于多区组(中位数:48.5 比 33.4 个月,p=0.001,CI:32.05-46.62,和 20.4 比 10.6 个月,p<0.001,CI:13.84-21.03)。在单区淋巴结转移组中,单区和多区淋巴结转移组的总生存和无病生存差异无统计学意义。
与多区转移组相比,单区淋巴结转移患者的预后较好。即使有两个或更多的淋巴结站受累,如果受累的淋巴结局限于单个淋巴结区,预后仍然良好。总之,单区淋巴结转移的患者可以从手术切除中获益。